Pain News and Research

Latest Pain News and Research

Study shows association between physical activity, reduced mortality among breast cancer survivors

Breast cancer survivors are among the women who could most benefit from regular physical activity, yet few meet national exercise recommendations during the 10 years after being diagnosed, according to a study by researchers at Fred Hutchinson Cancer Research Center.

18 Apr 2013

Phase IIa study shows safety and efficacy of BL-7040 in treating ulcerative colitis

BioLineRx, a biopharmaceutical development company, announced today positive Phase IIa results for BL-7040, an orally available drug for treating inflammatory bowel disease.

17 Apr 2013

First Edition: April 17, 2013

Today's headlines include reports about a new study finding that surgical woes can actually bolster a hospital's profits.

17 Apr 2013

UCSF study evaluates genetic predictors of lymphedema in women

A new UCSF study has found a clear association between certain genes and the development of lymphedema, a painful and chronic condition that often occurs after breast cancer surgery and some other cancer treatments.

17 Apr 2013

Science behind medical acupuncture

A special issue of Medical Acupuncture presents a series of articles by authors from around the world who provide diverse and insightful perspectives on the science and physiologic responses underlying medical acupuncture.

17 Apr 2013

UI Health to launch EPIC program to cut frequent ER visits, readmissions to hospital

The University of Illinois Hospital & Health Sciences System is taking steps to reduce frequent emergency room visits and readmissions to the hospital.

17 Apr 2013

Acetaminophen may help reduce existential pain

Thinking about death can cause us to feel a sort of existential angst that isn't attributable to a specific source. Now, new research suggests that acetaminophen, an over-the-counter pain medication, may help to reduce this existential pain.

17 Apr 2013

GlycoMimetics reports Phase 2 clinical study results of GMI-1070

GlycoMimetics, Inc. today announced top line clinical results from a Phase 2 study of GMI-1070 in patients experiencing vaso-occlusive crisis of sickle cell disease.

17 Apr 2013

Updated labeling for Purdue Pharma's reformulated OxyContin tablets gets FDA approval

The U.S. Food and Drug Administration today approved updated labeling for Purdue Pharma L.P.'s reformulated OxyContin (oxycodone hydrochloride controlled-release) tablets.

17 Apr 2013

Large numbers of ER visits go unreported in calculating hospital readmission rates

A study led by researchers at the Perelman School of Medicine at the University of Pennsylvania and Boston University School of Medicine has found that nearly one quarter of patients may return to the emergency department within 30 days of being discharged from a hospitalization.

17 Apr 2013

New generation of innovative medical devices to be created by Curie-Cancer and Vygon partnership

Curie-Cancer, the body responsible for developing Institut Curie’s industry partnership activities and Vygon, a French family-run business that develops, produces and markets medical devices, including catheters and implantable ports for administering chemotherapy treatments, today announce their partnership to develop a new generation of innovative medical devices; mainly for use in chemotherapy. The partnership aims to introduce them to European, the US and Asian markets.

16 Apr 2013

COPD phase III study by Almirall and Forest Laboratories announces positive results

Almirall, S.A. (ALM:MC) and Forest Laboratories, Inc. (NYSE:FRX) today announced positive topline results from a six month pivotal phase III clinical trial evaluating the efficacy and safety of fixed dose combinations of aclidinium bromide (LAMA) and formoterol fumarate (LABA) delivered by Almirall’s inhaler Genuair® (Pressair™ in the USA).

16 Apr 2013

Research suggests fainting may be genetic while certain triggers may not be inherited

New research suggests that fainting may be genetic and, in some families, only one gene may be responsible. However, a predisposition to certain triggers, such as emotional distress or the sight of blood, may not be inherited.

16 Apr 2013

Study: Women with RA exposed to anti-tumor necrosis drugs may have increased abortion rates

A new study published in the American College of Rheumatology (ACR) journal, Arthritis Care & Research, reveals that women with rheumatoid arthritis (RA) who were on methotrexate (MTX), a drug commonly used to reduce inflammation caused by RA, had lower rates of induced abortions compared to women with RA who were not exposed to the medication.

16 Apr 2013

Institut de France awards 2013 Grand Prix Scientifique to Penn Medicine researcher

Garret FitzGerald MD, FRS, chairman of the Pharmacology Department and director of the Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, has been awarded the 2013 Grand Prix Scientifique by the Institut de France.

16 Apr 2013

Electroconvulsive therapy improves quality of life in patients with severe depression

Patients whose severe depression goes into remission for six months following electroconvulsive therapy report a quality of life similar to that of healthy individuals, researchers say.

16 Apr 2013

Evoking illusion of having phantom hand in non-amputated individuals possible, study shows

The sensation of having a physical body is not as self-evident as one might think. Almost everyone who has had an arm or leg amputated experiences a phantom limb: a vivid sensation that the missing limb is still present.

16 Apr 2013

Carticept Medical gets FDA clearance for Navigator Delivery System

Carticept Medical, Inc., a developer of innovative drug delivery systems, announced today that it has received 510(k) clearance from the Food and Drug Administration for its enhanced Navigator Delivery System, the first and only FDA-cleared, computer-controlled injection system intended to increase the efficiency, comfort, safety and accuracy of musculoskeletal injections.

16 Apr 2013

Acorda Therapeutics reports positive data from dalfampridine-ER post-stroke deficits trial

Acorda Therapeutics, Inc. today announced that a proof-of-concept trial found dalfampridine extended release tablets, marketed as AMPYRA (dalfampridine) Extended Release Tablets, 10 mg, improved walking in people with post-stroke deficits.

16 Apr 2013

Bioactive plasma-based biomaterials can accelerate tissue healing

Platelet-rich plasma derived from blood contains growth factors and other bioactive molecules that promote healing at sites of tissue injury. However, it is difficult to deliver and retain these molecules at a target site, and clinical results have proven to be mixed - until now.

16 Apr 2013

Pain News and Research

Latest Pain News and Research

Study shows association between physical activity, reduced mortality among breast cancer survivors

Phase IIa study shows safety and efficacy of BL-7040 in treating ulcerative colitis

First Edition: April 17, 2013

UCSF study evaluates genetic predictors of lymphedema in women

Science behind medical acupuncture

UI Health to launch EPIC program to cut frequent ER visits, readmissions to hospital

Acetaminophen may help reduce existential pain

GlycoMimetics reports Phase 2 clinical study results of GMI-1070

Updated labeling for Purdue Pharma's reformulated OxyContin tablets gets FDA approval

Large numbers of ER visits go unreported in calculating hospital readmission rates

New generation of innovative medical devices to be created by Curie-Cancer and Vygon partnership

COPD phase III study by Almirall and Forest Laboratories announces positive results

Research suggests fainting may be genetic while certain triggers may not be inherited

Study: Women with RA exposed to anti-tumor necrosis drugs may have increased abortion rates

Institut de France awards 2013 Grand Prix Scientifique to Penn Medicine researcher

Electroconvulsive therapy improves quality of life in patients with severe depression

Evoking illusion of having phantom hand in non-amputated individuals possible, study shows

Carticept Medical gets FDA clearance for Navigator Delivery System

Acorda Therapeutics reports positive data from dalfampridine-ER post-stroke deficits trial

Bioactive plasma-based biomaterials can accelerate tissue healing

Pharmaceutical Manufacturing - Industry Focus eBook eBook

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Pain News and Research

Latest Pain News and Research

Pharmaceutical Manufacturing - Industry Focus eBook eBook

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Newsletters you may be interested in